VITL
Vital Farms, Inc.32.20
-2.33-6.75%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Reaffirms guide; details ERP recovery
Q&A largely reaffirmed the prepared guide's conservatism amid category volatility and ERP aftermath, with management stressing volume share gains despite glut-driven shelf noise. They clarified ERP caused temporary shelf losses now recovering via retailer reset talks, yielding expansion green shoots for top SKUs. Promotions mark a return to full-year normalcy, reinvesting prior price hikes without escalation. First-ever $100M buyback authorization responds directly to shareholder balance sheet questions. Q&A adds execution color, not contradictions. Shelf recovery accelerates growth. Watch Q1 shipments versus back-half ramp.
Key Stats
Market Cap
1.44BP/E (TTM)
24.39Basic EPS (TTM)
1.32Dividend Yield
0%Recent Filings
8-K
Strong results, leadership shift
Vital Farms reported FY2025 net revenue of $759.4M, up 25.3%, with net income rising to $66.3M. Founder Matt O'Hayer resigned as Executive Chairperson effective February 24, 2026; CEO Russell Diez-Canseco steps in. Board approved $100M share repurchase through 2028. Leadership unites. FY2026 guides $900-920M revenue.
10-K
FY2025 results
Vital Farms crushed FY2025 ended December 28 with net revenue jumping 25% y/y to $759.4M, powered by 13% volume growth and price/mix gains, as shell eggs (97% of sales) hit $733.2M amid HPAI-driven premium demand. Q4 momentum accelerated with ERP system go-live despite brief disruptions, new Moba grader boosting Egg Central Station to 7.5M eggs/day capacity, and groundbreaking on Indiana's Vital Crossroads plant (2027 operational). Gross margins held steady at 38% despite labor/overhead scaling, while SG&A rose 19% on marketing/tech investments; free cash flow not disclosed. $113M liquidity funds $120-140M capex ahead. Avian disease outbreaks risk supply shocks.
8-K
$2B revenue target 2030
Vital Farms set a $2 billion net revenue target for 2030, with 35+% gross margins through 2030 and 15-17% adjusted EBITDA margins. FY2025 guidance tightened to $755-765M revenue and >$115M adjusted EBITDA, despite ERP hiccups now resolved. Vital Crossroads facility unlocks 2027 capacity. Targets hinge on supply chain scale.
10-Q
Q3 FY2025 results
Vital Farms crushed Q3 with net revenue jumping 37% y/y to $198.9M on volume gains and price/mix tailwinds, driving operating income up 131% y/y to $21.4M while gross margin edged to 37.7% amid scaling investments. Diluted EPS doubled to $0.36 on 46.2M shares, matching YTD trends at $1.09. Cash from operations fell to $27.9M YTD on working capital swings, yet $145M in cash and securities plus $60M revolver availability back heavy capex for Indiana facility and accelerator farms. Derivative losses hit other expense. Outbreaks of avian influenza and egg drop syndrome loom large.
8-K
Q3 revenue up 37.2%
CALM
Cal-Maine Foods, Inc.
86.15-1.87
COCO
The Vita Coco Company, Inc.
52.21-1.82
DOLE
Dole plc
15.35-0.21
EDBL
Edible Garden AG Incorporated
1.19+0.04
ESGH
ESG Inc.
4.40-0.98
FARM
Farmer Brothers Company
1.49+0.01
PFAI
Pinnacle Food Group Limited
2.21-0.06
TSN
Tyson Foods, Inc.
58.19-1.34
VFF
Village Farms International, In
4.14+0.36
VTLE
Vital Energy, Inc.
17.92+0.00